OKYO Pharma Limited
OKYO Pharma Limited (EMMLF) Revenue
Annual & quarterly revenue history · segment & region breakdown
EMMLF · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsOKYO Pharma Limited trailing twelve-month (TTM) revenue is $0.00B, an increase of 0.00% year-over-year from — in FY.
Revenue trend
– · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|
About Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income OKYO Pharma Limited receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
OKYO Pharma Limited reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from OKYO Pharma Limited's 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
EMMLF revenue · 4 questionsEMMLF's trailing twelve-month (TTM) revenue is $0.00B. That is an increase of 0.00% year-over-year from — in FY.
▸ Source: FMP · OKYO Pharma Limited SEC filings · GAAP · OKYO Pharma Limited SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026